{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:50:54Z","timestamp":1790945454785,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012365","name":"Howard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.phrs.2003.07.014","type":"journal-article","created":{"date-parts":[[2003,11,7]],"date-time":"2003-11-07T10:56:24Z","timestamp":1068202584000},"page":"161-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"title":["Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models"],"prefix":"10.1016","volume":"49","author":[{"given":"Magnus A","family":"Azuine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harukuni","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junko","family":"Takayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Enjyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Mukainaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Konoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyoku","family":"Nishino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind J","family":"Kapadia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2003.07.014_BIB1","first-page":"1","article-title":"Chemoprevention of cancer","volume":"45","author":"Wattenberg","year":"1985","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-8741(94)01188-5","article-title":"Adjuvant chemoprevention of experimental cancer: catechin and dietary turmeric in forestomach and oral cancer models","volume":"44","author":"Azuine","year":"1994","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.1994.12.4.851","article-title":"Cancer chemoprevention","volume":"12","author":"Lippman","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0147-0272(94)90003-5","article-title":"Chemoprevention of cancer","volume":"18","author":"Szarka","year":"1994","journal-title":"Curr. Prob. Cancer"},{"key":"10.1016\/j.phrs.2003.07.014_BIB5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0891-5849(89)90124-X","article-title":"Antioxidants and multistage carcinogenesis in mouse skin","volume":"7","author":"Perchellet","year":"1989","journal-title":"Free Rad. Biol. Med."},{"key":"10.1016\/j.phrs.2003.07.014_BIB6","unstructured":"Gordon M, editor. Medicinal chemistry, vol. 4.; Psychopharmacological agents, vol. 3. New York: Academic Press; 1974."},{"key":"10.1016\/j.phrs.2003.07.014_BIB7","unstructured":"Gilman AG, Rall TW, Nies AS, et al., (Eds). Goodman and Gilman\u2019s the pharmacological basis of therapeutics. New York: Pergamon Press; 1990."},{"key":"10.1016\/j.phrs.2003.07.014_BIB8","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1002\/1097-0142(196712)20:12<2194::AID-CNCR2820201220>3.0.CO;2-M","article-title":"Cancer mortality among patients in New York mental hospitals","volume":"12","author":"Katz","year":"1967","journal-title":"Cancer"},{"key":"10.1016\/j.phrs.2003.07.014_BIB9","first-page":"1912","article-title":"Antineoplastic effect of chlorpromazine in chemical carcinogenesis in the hamster cheek pouch","volume":"32","author":"Polliack","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB10","first-page":"925","article-title":"Effect of chlorpromazine hydrochloride on carcinogen-metabolizing enzymes: liver microsomal dimethylnitrosamine demethylase, 4-dimethylaminoazobenzene reductase, and aryl hydrocarbon hydroxylase","volume":"64","author":"Mostafa","year":"1980","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.phrs.2003.07.014_BIB11","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ijc.2910330412","article-title":"Induction of Epstein-Barr virus antigens by tumor promoters for epidermal and nonepidermal tissues","volume":"33","author":"Takada","year":"1984","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phrs.2003.07.014_BIB12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01629428","article-title":"Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo(a)pyrene-induced genotoxicity and carcinogenicity","volume":"118","author":"Azuine","year":"1992","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0027-5107(97)00292-3","article-title":"Mechanisms of mutagenesis and carcinogenesis","volume":"402","author":"De Flora","year":"1998","journal-title":"Mutat. Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB14","first-page":"199","article-title":"Perspectives on cancer chemoprevention research and drug development","volume":"78","author":"Kellof","year":"2000","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1271\/bbb.62.377","article-title":"Detection of antitumor promoting activity in Raji cells carrying Epstein-Barr virus genome by immunoblotting analysis","volume":"62","author":"Kondo","year":"1998","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.phrs.2003.07.014_BIB16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0304-3835(00)00538-3","article-title":"Antitumor-promoting effects of cyclic diarylheptanoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis","volume":"159","author":"Ishida","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1021\/np50064a039","article-title":"Studies on inhibitors of skin tumor promotion: inhibitory effects of triterpenes from Cochlospermum tinctorium on Epstein-Barr virus activation","volume":"52","author":"Diallo","year":"1989","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2003.07.014_BIB18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3835(81)90083-5","article-title":"A short-term in vitro assay for promoter substances using human lymphoblastoid cells latently infected with Epstein-Barr virus","volume":"13","author":"Ito","year":"1981","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0304-3835(92)90208-D","article-title":"Inhibitory effects of dihydroagarofuran sesquiterpenes on Epstein-Barr virus activation","volume":"65","author":"Takaishi","year":"1992","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0304-3835(95)04087-0","article-title":"Chemoprevention of lung and skin cancer by Beta vulgaris (beet) root extract","volume":"100","author":"Kapadia","year":"1996","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/07357909109021328","article-title":"Antitumor properties of phenothiazines","volume":"9","author":"Motohashi","year":"1991","journal-title":"Cancer Invest."},{"key":"10.1016\/j.phrs.2003.07.014_BIB22","first-page":"3409","article-title":"The primary in vitro antitumor screening of \u201chalf-mustard type\u201d phenothiazines","volume":"17","author":"Wuonola","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB23","first-page":"337","article-title":"The primary in vitro anticancer screening of \u201chalf-mustard type\u201d phenothiazines in NCI\u2019s revised anticancer screening paradigm","volume":"18","author":"Wuonola","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB24","first-page":"839","article-title":"Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis","volume":"17","author":"Tanaka","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3835(97)04726-5","article-title":"Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced Epstein-Barr virus early antigen activation by natural colorants","volume":"115","author":"Kapadia","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(98)00087-1","article-title":"Cancer chemopreventive activity of synthetic colorants used in food, pharmaceuticals and cosmetic preparations","volume":"129","author":"Kapadia","year":"1998","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB27","first-page":"361","article-title":"Cytotoxicity of phenothiazines: studies with aerated and hypoxic cells","volume":"56","author":"Lehnert","year":"1987","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB28","first-page":"1952","article-title":"Inhibition of the growth of mouse melanoma by chlorpromazine","volume":"29","author":"Melvin","year":"1969","journal-title":"Cancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB29","first-page":"1247","article-title":"Immunomodulating activities on cellular cytotoxicity and the blast transformation of human lymphocytes by 10-[n-(phthalimido)alkyl-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazin-10-yl)alkyl-1-ureas","volume":"16","author":"Petri","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB30","first-page":"13","article-title":"Induction of a protective immunity in mice against Escherichia coli by phenothiazines, 10-[n-(phthalimido)alkyl]-2-substituted-10H-phenothiazines and 1-(2-chloroethyl)-3-(2-substituted-10H-phenothiazines-10-yl)alkyl-1-ureas","volume":"11","author":"Komatsu","year":"1997","journal-title":"In Vivo"},{"key":"10.1016\/j.phrs.2003.07.014_BIB31","first-page":"2533","article-title":"Induction of DNA fragmentation in human myelogenous leukemic cell lines by phenothiazine-related compounds","volume":"15","author":"Sakagami","year":"1995","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB32","first-page":"791","article-title":"Cytotoxic and radiosensitizing effects of chlorpromazine hydrochloride in sarcoma 180A","volume":"18","author":"Shenoy","year":"1980","journal-title":"Ind. J. Exp. Biol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0027-5107(81)90098-1","article-title":"The effect of substituted phenothiazines on the mutagenicity of benzo(a)pyrene","volume":"80","author":"Kittle","year":"1981","journal-title":"Mutat. Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB34","first-page":"3625","article-title":"Antimutagenicity of benzo[a]phenothiazines in chemically induced mutagenesis","volume":"16","author":"Tanaka","year":"1996","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB35","first-page":"381","article-title":"Antimutagenicity of phenothiazine-metal co-ordination complexes in chemically induced mutagenesis","volume":"17","author":"Tanaka","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(96)04582-X","article-title":"Anti-tumor promoting effects of naphthoquinone derivatives on short term Epstein-Barr early antigen activation assay and in mouse skin carcinogenesis","volume":"113","author":"Kapadia","year":"1997","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB37","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3835(00)00331-1","article-title":"Anti-tumor promoting effects of isoflavonoids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis","volume":"152","author":"Ito","year":"2000","journal-title":"Cancer Lett."},{"key":"10.1016\/j.phrs.2003.07.014_BIB38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0006-2952(66)90026-8","article-title":"The surface activity of phenothiazine derivatives at the air\u2013solution interface","volume":"15","author":"Zografi","year":"1966","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0026-895X(25)10091-6","article-title":"Structural features determining activity of phenothiazines and related drugs for inhibition of cell growth and reversal of multidrug resistance","volume":"35","author":"Ford","year":"1989","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.phrs.2003.07.014_BIB40","first-page":"2863","article-title":"Inhibition of P-glycoprotein transport function by N-acylphenothiazines","volume":"22","author":"Wesolowska","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB41","first-page":"2833","article-title":"Interaction between various resistance modifiers and apoptosis inducer 12H-benzo(alpha) phenothiazine","volume":"22","author":"Mucsi","year":"2002","journal-title":"Anticancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/med.2610110302","article-title":"Potential antitumor phenoxazines","volume":"11","author":"Motohashi","year":"1991","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2003.07.014_BIB43","first-page":"704","article-title":"Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo","volume":"7","author":"Shimamoto","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phrs.2003.07.014_BIB44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00001813-200104000-00011","article-title":"Prevention of growth of human lung carcinoma cells and induction of apoptosis by a novel phenoxazinone, 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one","volume":"12","author":"Abe","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phrs.2003.07.014_BIB45","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00001813-200009000-00010","article-title":"Antitumor activity of 2-amino-4,4alpha-dihydro-4alpha,7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB\/c mice","volume":"11","author":"Mori","year":"2000","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phrs.2003.07.014_BIB46","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0959-8049(99)00164-1","article-title":"Cancer chemoprevention: progress and promise","volume":"35","author":"Kellof","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.phrs.2003.07.014_BIB47","first-page":"78","article-title":"Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis","volume":"6","author":"van Stolk","year":"2000","journal-title":"Clin. Cancer Res."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661803002780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661803002780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:50:40Z","timestamp":1760910640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661803002780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S1043661803002780"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2003.07.014","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer chemopreventive effect of phenothiazines and related tri-heterocyclic analogues in the 12-O-tetradecanoylphorbol-13-acetate promoted Epstein-Barr virus early antigen activation and the mouse skin two-stage carcinogenesis models","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2003.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}